Navigation Links
BullMarket.com Updates Outlook on Biotech Stocks
Date:3/12/2009

PRINCETON, N.J., March 12 /PRNewswire-FirstCall/ -- BullMarket.com (http://www.bullmarket.com), an online investment newsletter focused on long-term growth and income-generating stocks, has provided subscribers with updated coverage of several biotech stocks, including Amgen (Nasdaq: AMGN), Gilead Sciences (Nasdaq: GILD), Celgene (Nasdaq: CELG), Genzyme (Nasdaq: GENZ), and Vertex Pharmaceuticals (Nasdaq: VRTX).

All paid and trial subscribers to BullMarket.com can now receive immediate access to the newsletter's exclusive daily reports. As a subscriber, you'll also gain access to our Recommended List of stocks, which outperformed the S&P 500 by 15% in 2008.

Start your 14-day free trial today:

https://www.bullmarket.com/subscribe/pr/?refer=BMR500P

In its daily report, BullMarket.com wrote: "The Pfizer-Wyeth combo, followed quickly by the Merck-Schering announcement, laid waste to the notion that Big Pharma was coveting successful biotechs. (It is, we suppose, another example of why investors should cover their ears when they hear 'conventional wisdom' and 'Wall Street' in the same sentence.) Granted, Europe's Roche Holdings today bought the portion of Genentech that it doesn't already own, but in this case, the two companies have a long-standing relationship and the latter made sure it extracted the highest possible price."

BullMarket.com looked at the following topics, among others:

-- What drug candidate could turn Amgen back into a growth story in 2010?

-- Why does Vertex's recent purchase of ViroChemPharma look like a smart move?

-- How does Celgene's principal drug Revlimid have an advantage over other multiple myeloma treatments?

-- What event has been a real black eye for Genzyme?

-- What recent event demonstrates that it will be difficult for generic drug companies to produce generic versions of biologics?

-- Is now the time to buy biotech stocks, and which ones look the most promising?

About BullMarket.com:

Launched in 1997, BullMarket.com has a strong track record of creating wealth for its subscribers by providing sound, long-term investing advice. The BullMarket.com Recommended List includes about 50 companies across all major industries, including Financials, Healthcare, Energy, Technology, and Retail, among others. BullMarket.com is one of the oldest continuously published investment newsletters online, and its Recommended List has consistently outperformed the major market indices.

NOTE: This release was published by Indie Research Advisors, LLC, a registered investment advisor with CRD #131926. Interested parties may visit adviserinfo.sec.gov for additional information. Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.

Contact:

Marcie Martin, Bull Market Report, +1-888-278-5515


'/>"/>
SOURCE Indie Research Advisors, LLC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. BullMarket.com Examines Stem Cell Stocks
2. BullMarket.com Examines Healthcare IT Stocks
3. Alexza Reports 2008 Year-End Financial Results and Updates Clinical Pipeline Status
4. Cell Therapeutics Updates Shareholders on Trading
5. Service Corporation International Updates Fourth Quarter 2008 Guidance
6. NCCN Updates Breast Cancer and Breast Cancer Risk Reduction Guidelines
7. LegalView Updates Avandia Information Portal With New Articles Detailing Potentially Dangerous Side Effects
8. Medical Management Corporation Updates Medical Billing Services
9. Omnicell Updates 2008 Year End Guidance and Announces Company Reorganization
10. LegalView Updates Peanut Butter Recall Information Portal with Info on Salmonella Contaminations Among Several Tainted Food Products
11. CEO of Traxxec, Inc. updates on Intellectual Property
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... Little Rock, AR (PRWEB) , ... October 13, ... ... owned firm with locations throughout Arkansas that offers insurance and financial preparation services, ... to benefit the Rock City Rescue organization. , Rock City Rescue is a ...
(Date:10/13/2017)... ... 2017 , ... PurhealthRX , a leading Health and Nutrition Company, is ... to full spectrum CBD oil will revolutionize the rapidly growing CBD market by reducing ... easily incorporated into liquid products, while reducing costs to end users. , The team ...
(Date:10/13/2017)... , ... October 13, 2017 , ... The Visiting Nurse ... Market. Featuring a collection of specialty vendors and unique items from across the nation, ... quality-focused health and wellness services offered by the VNA. The boutique will be ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... Agile Software Development, has been awarded a contract by the Center for Medicare ... (BPA) aims to accelerate the enterprise use of Agile methodologies in a consistent ...
(Date:10/12/2017)... ... , ... Planet Fitness, one of the largest and fastest growing franchisors and ... flagship location in Covington, LA at 401 N. U.S. Highway 190, in January of ... Depot in the Holiday Square shopping center. Its location allows it to serve both ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... -- Halo Labs announces the European launch of their new low ... MIBio 2017 in Cambridge, U.K on October ... biopharmaceutical samples with unprecedented speed and sensitivity while using far less ... Imaging. ... analysis system ...
(Date:9/27/2017)... -- Commended for their devotion to personalized service, SMP Pharmacy Solutions ... in the South Florida Business Journal,s 50 Fastest-Growing Companies, and ... the national specialty pharmacy has found its niche.  To that ... be honored by SFBJ as the 2017 Power Leader in ... receive his award in October, Bardisa said of the three ...
(Date:9/23/2017)... Sept. 22, 2017 Janssen Biotech, Inc. (Janssen) ... letter from the U.S. Food and Drug Administration (FDA) ... sirukumab for the treatment of moderately to severely active ... clinical data are needed to further evaluate the safety ... active RA. ...
Breaking Medicine Technology: